Neutrophil Extracellular Traps in Central Nervous System Diseases
Authors:
Open Access
- 1 February 2026
- journal article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 24 (3) , 340-347
Abstract
Neutrophil Extracellular Traps (NETs) are complexes containing DNA fibrils and antimicrobial peptides that are released by neutrophils in response to pathogen stimulation. At the time of their discovery, the neutrophil extracellular trap contained active substances such as Neutrophil Elastase (NE) and myeloperoxidase (MPO). Although NETs were initially thought to be a means for the innate immune system to fight microbial invasion, now they have been observed to have a broader impact throughout the body. In recent studies, NETs have been linked to several neurological disorders and have been found to have varying roles in a number of diseases. In addition to their role in thrombosis, NETs have been identified in various autoimmune diseases. NETs play a significant role in the body when they are produced at the correct time and place; however, when the generation and removal of NETs are out of equilibrium, there can be important implications for human health. Here, the impact of NETs is reviewed in various neurological disorders and their potential clinical applications.Keywords
Funding Information
- Jilin Province Bethune Natural Science Foundation Project of China (20210101465JC)
This publication has 75 references indexed in Scilit:
- Association of Neutrophil Extracellular Traps with Plaque Instability in Patient with Carotid Artery StenosisAnnals of Vascular Surgery, 2022
- Neutrophil extracellular traps induce thrombogenicity in severe carotid stenosisImmunity, Inflammation and Disease, 2021
- Neutrophil Extracellular Traps may be a Potential Target for Treating Early Brain Injury in Subarachnoid HemorrhageTranslational Stroke Research, 2021
- Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findingsJapanese Journal of Radiology, 2020
- Functional Dynamics of Neutrophils After Ischemic StrokeTranslational Stroke Research, 2019
- Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activityBiochemical Pharmacology, 2018
- Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future DirectionsArthritis & Rheumatology, 2018
- Neutrophils in multiple sclerosis are characterized by a primed phenotypeJournal of Neuroimmunology, 2012
- Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosisJournal of Leukocyte Biology, 1996
- Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunctionThe American Journal of Medicine, 1983